Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Improving the Care Process for Patients with Advanced Prostate CancerRelease Date:Partner: The American Urological Association Education and Research, Inc.; AstellasQuality Improvement Oncology USA PARP-Inhibitor Combination Therapies: Personalized Treatment for Patients with Metastatic Castration-Resistant Prostate CancerRelease Date:Education Oncology Canada Developing Educational Initiatives for ALK+ Metastatic Non-small Cell Lung Cancer Tyrosine Kinase Inhibitors TherapyRelease Date:Education Oncology Canada Accelerating biomarker testing for optimized metastatic colorectal cancer treatment planning across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada 2025 Inflammatory Bowel Disease (IBD) Fellowship – United StatesRelease Date:Fellowship Inflammation & Immunology USA Transthyretin Cardiac Amyloidosis Fellowship - United StatesRelease Date:Fellowship Rare Disease USA Advances in Migraine ManagementRelease Date:Education Internal Medicine USA Exploring the Use of Artificial Intelligence (AI) Applications in ALK+ NSCLCRelease Date:Quality Improvement, Research Oncology Italy Sickle Cell Disease (SCD) FellowshipRelease Date:Fellowship Rare Disease USA Global Call for Collaborators – Pfizer RSV OA ResearchRelease Date:Research Vaccines All 2025 Headache Medicine Fellowship - USRelease Date:Fellowship Internal Medicine USA Title Grant Type Focus Area Country Application Due Date Transition of Care in VTERelease Date:Anticoagulation Education - NVAF or VTERelease Date:Review Process:Achievement of Treat-to-Target in Rheumatoid ArthritisRelease Date:Improving Care of Chronic Pain- Physician Groups and Health SystemsRelease Date:Facilitation of the Diagnosis of Rheumatoid ArthritisRelease Date:Pfizer and NCCN: Metastatic Breast CancerRelease Date:Pediatric Immunization Series CompletionRelease Date:Pfizer and National Psoriasis Foundation (NPF): Plugging the Treatment Gap in Psoriasis and Psoriatic ArthritisRelease Date:Pfizer and International Atherosclerosis Society (IAS): Lipid Management in High-Risk PatientsRelease Date:Pfizer and American Academy of Dermatology (AAD): Patient Access to CareRelease Date:Narrowing the Time Gap between Onset of Symptoms and Treatment for Rheumatoid ArthritisRelease Date: